Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of Intravenous Hydroxocobalamin Versus Methylene Blue as Treatment for Intraoperative Vasoplegic Syndrome in Liver Transplant Patients

NCT04054999 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT04054999
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04054999 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of Intravenous Hydroxocobalamin Versus Methylene Blue as Treatment for Intraoperative Vasoplegic Syndrome in Liver Transplant Patients
Lead sponsor
Mayo Clinic
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2019
Completion date
February 27, 2024
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver transplant; complications, vasoplegic syndrome